Skip to Accessibility Menu Skip to Login Skip to Content Skip to Footer

News

FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions image

FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions

The U.S. Food and Drug Administration (FDA) has granted approval for Cytalux® (pafolacianine) for use in adults with ovarian cancer. Cytalux is...

By Editorial Team

2 min read

Stay connected with the community

By providing your email address, you are agreeing to our Privacy Notice and Terms of Use.

AdvancedOvarianCancer.net is a Health Union community. Health Union reaches millions of people through condition-specific online health communities and a Social Health Network of patient leaders across virtually all health conditions.

OUR COMMUNITIES

About Us
Terms of Use
Privacy Notice
Your Privacy Choices
Community Rules
Ad Choices

© 2025 Health Union, LLC. All rights reserved. This information is not designed to replace a physician’s independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. AdvancedOvarianCancer.net does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.